New hope for stubborn blood disorder: old drug tested in new way
NCT ID NCT05599880
Summary
This study is testing if a drug called bortezomib can help adults with a hard-to-treat form of immune thrombocytopenia (ITP), where the immune system attacks platelets. It aims to see if the drug can safely raise and maintain platelet counts in people whose ITP has come back or hasn't responded to at least two other standard treatments. The trial involves about 29 participants and will monitor them for a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY IMMUNE THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
SMG-SNU Boramae Medical Center
RECRUITINGSeoul, 07061, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Seoul National University Bundang Hospital
RECRUITINGGuri-si, South Korea
Contact
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
Contact
-
Seoul National University Hospital
NOT_YET_RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.